New Model for Lung Cancer Screening Selection Criteria Shown to Be More Effective
by: Joseph St. Pierre
Recommending lung cancer screening on patients deemed to be high-risk
according to the current model developed by National Lung Cancer Trial (NLCT)
has been shown to lower the overall mortality rate of the disease by 20%.The
applied criteria include being between 55 and 74 years of age, having a history
of smoking of at least 30 pack-years, a period of less than 15 years since
cessation of smoking, or a modified set of requirements based on the former
criteria. However, according to an article published by the New England Journal
of Medecine, researchers have developed a modified model based off of risk
factors used in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer
Screening Trial. The new model, which analyzes additional risk-based factors
like BMI, family history, and smoking status, has be shown to be significantly
more efficient at marking patients as high-risk and increasing diagnosis yield.
The study was performed by analyzing the intervention and control group data
of the two aforementioned studies, NLCT and PLCO, which encompassed 53,202 and
80,375 smokers, respectively. An additional group composed of 15,099 PLCO
intervention group members who met the NLST criteria was also included.
Statistical analysis compared the effectiveness of the new, modified PLCO
risk-based model, named PLCOM2012 , with the unmodified
NLCT criteria. Compared to NLCT criteria, PLCOM2012 had
significantly increased sensitivity and positive predictive value, allowing it
to miss 41.3% less lung cancer diagnoses.
While
this data may imply that PLCOM2012 is an obvious improvement over current lung cancer
screening methods, it should be noted that PLCOM2012 is far more
difficult to apply than its predecessor, as it hinges on complex modeling and the use of multivariate statistics.
Furthermore, PLCOM2012 occasionally uses parameters, such
as follow-up time, that differ from its older counterpart, rendering certain comparisons inaccurate.
However, in dealing with an affliction whose early detection is key to
successful treatment, such findings and research are, at the very least, yet
another step towards more a more efficient means of recognizing at-risk
individuals.
NEJM. 2013. 368:728-736
Joseph St. Pierre is the 2012-2013 Tuftscope Research Highlights Editor
Monday, February 25, 2013
Research Highlights: New Model for Lung Cancer Screening More Effective, Study Shows
Labels:
Research Highlights
blog comments powered by Disqus
Subscribe to:
Post Comments (Atom)